SIIP Clinical Research / Shanghai Yilinsi
SIIP’s official business page identifies Shanghai Yilinsi clinical services covering Phase I–IV, human PK, bioequivalence and international multicentre studies. Confirm English project staffing and recent overseas sponsor references.
Corporate information
- Company entity
- SIIP Clinical Research / Shanghai Yilinsi
- Headquarters / principal office
- China-based / China-origin platform ↗
- Founded
- Not verified in this review
- Ownership / capital status
- Not verifiedSee entity-specific disclosures; group figures are not clinical revenue
- Official corporate reference
- https://www.csipi.com.cn/portal/list/index/id/78.html ↗
- LinkedIn company page
- Independent company page not verified
Profile review: 2026-11-06 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Public evidence snapshot
SIIP’s official business page identifies Shanghai Yilinsi clinical services covering Phase I–IV, human PK, bioequivalence and international multicentre studies. Confirm English project staffing and recent overseas sponsor references.
This profile is a research snapshot, not a company endorsement. Check original sources for current information.